Sinsinpas Pain Relieving Patch
NDC Package 55264-101-03
Package Information
Sinsinpas Pain Relieving Patch is adults and children 12 years of age and over:Clean and dry affected areaRemove patch from filmApply to affected area no more than 3 to 4 times daily for 7 daysRemove patch from skin after at most 8 hours’ applicationChildren undress 12 years of age: consult a doctor. Marketed by Sinsin Pharmaceutical Co., Ltd., this product is identified by NDC 55264-101 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 2102942 - camphor 1.21 % / L-menthol 5.54 % / methyl salicylate 6.11 % Medicated Patch
- RxCUI: 2102942 - camphor 5560 MG / levomenthol 2550 MG / methyl salicylate 28100 MG Medicated Patch
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 55264 - Sinsin Pharmaceutical Co., Ltd.
- 55264-101 - Sinsinpas Pain Relieving Patch
- 55264-101-03 - 2 POUCH in 1 PACKAGE / 20 PATCH in 1 POUCH (55264-101-02) / 459.93 g in 1 PATCH (55264-101-01)
- 55264-101 - Sinsinpas Pain Relieving Patch
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55264-101-03 identifies a specific commercial package of 2 pouch in 1 package / 20 patch in 1 pouch (55264-101-02) / 459.93 g in 1 patch (55264-101-01) of Sinsinpas Pain Relieving Patch, labeled by Sinsin Pharmaceutical Co., Ltd.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sinsin Pharmaceutical Co., Ltd. on May 01, 2017. The current certification is valid through December 31, 2025.
How is this Sinsin Pharmaceutical Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55264010103. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.